Cargando…
Chemical Artificial Internalizing Receptors for Primary T Cells
The newest generation of cell‐based technologies relies heavily on methods to communicate to the engineered cells using artificial receptors, specifically to deactivate the cells administered to a patient in the event of adverse effects. Herein, artificial synthetic internalizing receptors are engin...
Autores principales: | Monge, Pere, Tvilum, Anne, Søgaard, Ane Bretschneider, Løvschall, Kaja Borup, Jarlstad Olesen, Morten T., Zelikin, Alexander N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509642/ https://www.ncbi.nlm.nih.gov/pubmed/32999846 http://dx.doi.org/10.1002/advs.202001395 |
Ejemplares similares
-
Synthetic Artificial Apoptosis‐Inducing Receptor for On‐Demand Deactivation of Engineered Cells
por: Monge, Pere, et al.
Publicado: (2021) -
Transmembrane signaling by a synthetic receptor in artificial cells
por: Søgaard, Ane Bretschneider, et al.
Publicado: (2023) -
Chemical zymogens for the protein cysteinome
por: Montasell, Mireia Casanovas, et al.
Publicado: (2022) -
Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects
por: Zuwala, Kaja, et al.
Publicado: (2018) -
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
por: Groß, Rüdiger, et al.
Publicado: (2022)